These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 24471378

  • 1. In vitro anti-inflammatory activity of selected oxalate-degrading probiotic bacteria: potential applications in the prevention and treatment of hyperoxaluria.
    Giardina S, Scilironi C, Michelotti A, Samuele A, Borella F, Daglia M, Marzatico F.
    J Food Sci; 2014 Mar; 79(3):M384-90. PubMed ID: 24471378
    [Abstract] [Full Text] [Related]

  • 2. Screening of different probiotic strains for their in vitro ability to metabolise oxalates: any prospective use in humans?
    Mogna L, Pane M, Nicola S, Raiteri E.
    J Clin Gastroenterol; 2014 Mar; 48 Suppl 1():S91-5. PubMed ID: 25291139
    [Abstract] [Full Text] [Related]

  • 3. Effect of a Probiotic Supplement Containing Lactobacillus Acidophilus and Bifidobacterium Animalis Lactis on Urine Oxalate in Calcium Stone Formers with Hyperoxaluria: A Randomized, Placebo-controlled, Double-blind and In-vitro Trial.
    Tavasoli S, Jalali S, Naji M, Borumandnia N, Shakiba Majd G, Basiri A, Khosravi Darani K, Karamad D, Tajabadi-Ebrahimi M, Taheri M.
    Urol J; 2021 Jun 15; 19(3):179-188. PubMed ID: 34129232
    [Abstract] [Full Text] [Related]

  • 4. Designer probiotic Lactobacillus plantarum expressing oxalate decarboxylase developed using group II intron degrades intestinal oxalate in hyperoxaluric rats.
    Paul E, Albert A, Ponnusamy S, Mishra SR, Vignesh AG, Sivakumar SM, Sivasamy G, Sadasivam SG.
    Microbiol Res; 2018 Oct 15; 215():65-75. PubMed ID: 30172310
    [Abstract] [Full Text] [Related]

  • 5. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?
    Hoppe B, von Unruh G, Laube N, Hesse A, Sidhu H.
    Urol Res; 2005 Nov 15; 33(5):372-5. PubMed ID: 16284877
    [Abstract] [Full Text] [Related]

  • 6. Metabolic activity of probiotics-oxalate degradation.
    Murphy C, Murphy S, O'Brien F, O'Donoghue M, Boileau T, Sunvold G, Reinhart G, Kiely B, Shanahan F, O'Mahony L.
    Vet Microbiol; 2009 Apr 14; 136(1-2):100-7. PubMed ID: 19028028
    [Abstract] [Full Text] [Related]

  • 7. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration.
    Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C.
    Kidney Int; 2001 Sep 14; 60(3):1097-105. PubMed ID: 11532105
    [Abstract] [Full Text] [Related]

  • 8. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease.
    Abratt VR, Reid SJ.
    Adv Appl Microbiol; 2010 Sep 14; 72():63-87. PubMed ID: 20602988
    [Abstract] [Full Text] [Related]

  • 9. Metabolomic profiling of oxalate-degrading probiotic Lactobacillus acidophilus and Lactobacillus gasseri.
    Chamberlain CA, Hatch M, Garrett TJ.
    PLoS One; 2019 Sep 14; 14(9):e0222393. PubMed ID: 31545840
    [Abstract] [Full Text] [Related]

  • 10. Association of intestinal oxalate-degrading bacteria with recurrent calcium kidney stone formation and hyperoxaluria: a case-control study.
    Tavasoli S, Alebouyeh M, Naji M, Shakiba Majd G, Shabani Nashtaei M, Broumandnia N, Basiri A.
    BJU Int; 2020 Jan 14; 125(1):133-143. PubMed ID: 31145528
    [Abstract] [Full Text] [Related]

  • 11. Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria.
    Siener R, Bade DJ, Hesse A, Hoppe B.
    J Transl Med; 2013 Dec 12; 11():306. PubMed ID: 24330782
    [Abstract] [Full Text] [Related]

  • 12. Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus.
    Turroni S, Vitali B, Bendazzoli C, Candela M, Gotti R, Federici F, Pirovano F, Brigidi P.
    J Appl Microbiol; 2007 Nov 12; 103(5):1600-9. PubMed ID: 17953571
    [Abstract] [Full Text] [Related]

  • 13. Simultaneous use of oxalate-degrading bacteria and herbal extract to reduce the urinary oxalate in a rat model: A new strategy.
    Afkari R, Feizabadi MM, Ansari-Moghadam A, Safari T, Bokaeian M.
    Int Braz J Urol; 2019 Nov 12; 45(6):1249-1259. PubMed ID: 31808414
    [Abstract] [Full Text] [Related]

  • 14. Analysis and Characterization of Lactobacillus paragasseri and Lacticaseibacillus paracasei: Two Probiotic Bacteria that Can Degrade Intestinal Oxalate in Hyperoxaluric Rats.
    Mehra Y, Rajesh NG, Viswanathan P.
    Probiotics Antimicrob Proteins; 2022 Oct 12; 14(5):854-872. PubMed ID: 35699895
    [Abstract] [Full Text] [Related]

  • 15. Effects of Lactobacillus casei and Bifidobacterium breve on urinary oxalate excretion in nephrolithiasis patients.
    Ferraz RR, Marques NC, Froeder L, Menon VB, Siliano PR, Baxmann AC, Heilberg IP.
    Urol Res; 2009 Apr 12; 37(2):95-100. PubMed ID: 19214493
    [Abstract] [Full Text] [Related]

  • 16. Use of a probiotic to decrease enteric hyperoxaluria.
    Lieske JC, Goldfarb DS, De Simone C, Regnier C.
    Kidney Int; 2005 Sep 12; 68(3):1244-9. PubMed ID: 16105057
    [Abstract] [Full Text] [Related]

  • 17. Recombinant Lactobacillus plantarum expressing and secreting heterologous oxalate decarboxylase prevents renal calcium oxalate stone deposition in experimental rats.
    Sasikumar P, Gomathi S, Anbazhagan K, Abhishek A, Paul E, Vasudevan V, Sasikumar S, Selvam GS.
    J Biomed Sci; 2014 Aug 30; 21(1):86. PubMed ID: 25175550
    [Abstract] [Full Text] [Related]

  • 18. Assessment of in vitro oxalate degradation by Lactobacillus species cultured from veterinary probiotics.
    Cho JG, Gebhart CJ, Furrow E, Lulich JP.
    Am J Vet Res; 2015 Sep 30; 76(9):801-6. PubMed ID: 26309108
    [Abstract] [Full Text] [Related]

  • 19. Enteric hyperoxaluria secondary to small bowel resection: use of computer simulation to characterize urinary risk factors for stone formation and assess potential treatment protocols.
    Rodgers AL, Allie-Hamdulay S, Jackson GE, Sutton RA.
    J Endourol; 2014 Aug 30; 28(8):985-94. PubMed ID: 24773381
    [Abstract] [Full Text] [Related]

  • 20. A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria.
    Goldfarb DS, Modersitzki F, Asplin JR.
    Clin J Am Soc Nephrol; 2007 Jul 30; 2(4):745-9. PubMed ID: 17699491
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.